Почетна › Рак дојке › Alabama › Birmingham
Kliničke studije za Рак дојке u gradu Birmingham, AL
24 studija za Рак дојке traži učesnike na lokacijama u gradu Birmingham i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
Тражи се учесникФаза 2
- O'Neal Comprehensive Cancer Center/The University of Alabama at Birmingham, Birmingham
An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- University of Alabama At Birmingham Hospital, Birmingham
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Тражи се учесникФаза 2
- University of Alabama Birmingham, Birmingham
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
Тражи се учесникНаводи исплату за учеснике
- University of Alabama at Birmingham, Birmingham
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Тражи се учесникФаза 2
- University of Alabama at Birmingham, Birmingham
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Тражи се учесникФаза 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors
Тражи се учесник
- UAB School of Health Professions, Birmingham
- University of Alabama at Birmingham O'Neal Cancer Center, Birmingham
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Тражи се учесникФаза 1
- University of Alabama Birmingham, Birmingham
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Тражи се учесникФаза 2
- Alabama Oncology, Birmingham
PRE-ISPY Phase I/II Oncology Platform Program
Тражи се учесникФаза 1/2
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
Тражи се учесникФаза 2
- University of Alabama at Birmingham, Birmingham
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
Тражи се учесник
- The Kirklin Clinic, Birmingham
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- University of Alabama at Birmingham, Birmingham
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Тражи се учесникЗдраве особе су добродошле
- University of Alabama at Birmingham, Birmingham
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Тражи се учесникОпсервациона студија
- Birmingham Hematology Associates, Birmingham
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Тражи се учесникФаза 2
- University of Alabama, Birmingham
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Тражи се учесникЗдраве особе су добродошле
- University of Alabama, Birmingham, Birmingham
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Тражи се учесникФаза 1
- Uni of Alabama at Birmingham, Birmingham
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Тражи се учесник
- The University of Alabama, Birmingham
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Тражи се учесникФаза 2
- University of Alabama at Birmingham, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Тражи се учесник
- University of Alabama at Birmingham, Birmingham
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Тражи се учесникФаза 2
- University of Alabama at Birmingham, Birmingham
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
Тражи се учесникРана фаза 1
- The Kirklin Clinic, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Birmingham
Studije za Рак дојке u drugim gradovima
- New York City, NY144 студија
- Houston, TX126 студија
- Boston, MA110 студија
- Nashville, TN78 студија
- Los Angeles, CA73 студија
- Edison, NJ70 студија
- Queens, NY67 студија
- Durham, NC63 студија
- St. Louis, MO63 студија
- Chicago, IL59 студија
- Dallas, TX54 студија
- Philadelphia, PA51 студија
Ostale studije u gradu Birmingham
- Рак (све врсте)30 студија
- Рак јајника25 студија
- Немалоклетни карцином плућа23 студија
- Гојазност22 студија
- Akutna mijeloidna leukemija21 студија
- ХОБП17 студија
- Многи мијелом17 студија
- Кардиоваскуларне болести16 студија
- Карцином ендометријума16 студија
- Гојазност16 студија
- Dijabetes tipa 216 студија
- Цистична фиброза15 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.